REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/02/2026
Back to search
Official data from USPTO
THE RNA PRINTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE RNA PRINTER
ST13
US500000088347483Class
1, 5, 42, 44
Filing
88347483
Registration
6285035
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
03/03/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
03/19/2019
Registration date
03/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2021
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Foreign priority
Drawing code
4
Owner type
27
Owner location
TUBINGEN, DE
Examiner
OESTREICHER, SALIMA PARMAR
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CUREVAC MANUFACTURING GMBH
CUREVAC RNA PRINTER GMBH
CureVac AG
Representatives
Jennifer Fraser DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents and biomoleculesin particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
Class 5
Chemical preparations for medical usefor therapeutic and prophylactic treatment of neurologicalneuromuscularneurodegenerativeinfectious and cardiovascular diseasesof autoimmune diseases and tumoursof allergiesof metabolic diseasesof heritable genetic diseasesfor therapies replacing proteins or enzymes; pharmaceutical preparationsimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of infectious diseasesautoimmune diseases and tumoursfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy productsnucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical usein particular substances for food supplementsdietary food supplements
Class 42
Scientific and technological servicestechnical biology consulting and scientific research servicesin particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules
Class 44
Medical and veterinary servicesin particular for therapeutic and preventative treatment of tumour diseasesinfectious diseasesautoimmune disorders and allergiesfor treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of metabolic disorders
Publications
History of USPTO decisions and trademark events.
34 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/04/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/25/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/02/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/28/2021
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/29/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/10/2020
GNFR
FINAL REFUSAL E-MAILED
07/10/2020
CNFR
FINAL REFUSAL WRITTEN
07/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2019
GNRT
NON-FINAL ACTION E-MAILED
12/05/2019
CNRT
NON-FINAL ACTION WRITTEN
12/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/05/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/04/2019
GNSL
LETTER OF SUSPENSION E-MAILED
11/04/2019
CNSL
SUSPENSION LETTER WRITTEN
11/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/15/2019
ALIE
ASSIGNED TO LIE
10/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/05/2019
GNRT
NON-FINAL ACTION E-MAILED
06/05/2019
CNRT
NON-FINAL ACTION WRITTEN
06/05/2019
DOCK
ASSIGNED TO EXAMINER
05/29/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/07/2019
NWAP
NEW APPLICATION ENTERED
03/22/2019
Continuous trademark protection
Get notified about every new filing that threatens THE RNA PRINTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.